EU enlargement and the evolution of European production networks
- 作者Louise Curran; Soledad Zignago
- 卷第26卷
- 期第2期
- 印刷ISSN0275-5319
- 文件大小394.32KB
- 发表时间2012
- DOI10.1016/j.ribaf.2011.12.002
- 页码240-257
Natural killer cell-mediated immunosurveillance of human cancerMalmberg, Karl-Johan; Carlsten, Mattias; Björklund, Andreas; Sohlberg, Ebba; Bryceson, Yenan T.; Ljunggren, Hans-Gustaf · Seminars in Immunology · 2017
Decline in natural killer cell-mediated immunosurveillance in aging mice — a consequence of reduced cell production and tumor binding capacityIsabelle Dussault; Sandra C. Miller · 1994
Lactate dehydrogenase-elevating virus enhances natural killer cell-mediated immunosurveillance of mouse mesothelioma developmentMandour, Mohamed F.; Soe, Pyone Pyone; Uyttenhove, Catherine; Van Snick, Jacques; Marbaix, Etienne; Coutelier, Jean-Paul · Infectious Agents and Cancer · 2020
Experimental appraisal of the lack of antitumor natural killer cell—mediated immunosurveillance in response to lymphomas growing in the mouse brainYamasaki, Toshiki; Moritake, Kouzo; Klein, George · Journal of Neurosurgery · 2003
Immunophenotyping of stage III melanoma reveals parameters associated with patient prognosisJacquelot, Nicolas; Roberti, María Paula; Enot, David P.; Rusakiewicz, Sylvie; Semeraro, Michaela; Jégou, Sarah; Flores, Camila; Chen, Lieping; Kwon, Byoung S.; Borg, Christophe; Weide, Benjamin; Aubin, François; Dalle, Stéphane; Kohrt, Holbrook; Ayyoub, Maha; Kroemer, Guido; Marabelle, Aurélien; Cavalcanti, Andréa; Eggermont, Alexander; Zitvogel, Laurence · Journal of Investigative Dermatology · 2016
Prognostic impact of the expression of NCR1 and 3 cell receptors and PD-L1 on advanced non-small cell lung cancerFend, Laetitia; Rusakiewicz, Sylvie; Adam, Julien; Bastien, Bérangère; Caignard, Anne; Messaoudene, Meriem; Iribarren, Christina; Cremer, Isabelle; Marabelle, Aurélien; Borg, Christophe; Semeraro, Michaela; Barraud, Luc; Limacher, Jean-Marc; Eggermont, Alexander; Kroemer, Guido; Zitvogel, Laurence · OncoImmunology · 2016
The immuno-oncology frameworkHoos, Axel; Britten, Cedrik M. · OncoImmunology · 2012
Myeloid derived suppressor cellsWaldron, Todd J.; Quatromoni, Jon G.; Karakasheva, Tatiana A.; Singhal, Sunil; Rustgi, Anil K. · OncoImmunology · 2013
Targeting cathepsin G in myeloid leukemiaAlatrash, Gheath · OncoImmunology · 2013
Trial watchSenovilla, Laura; Vacchelli, Erika; Garcia, Pauline; Eggermont, Alexander; Fridman, Wolf Hervé; Galon, Jérôme; Zitvogel, Laurence; Kroemer, Guido; Galluzzi, Lorenzo · OncoImmunology · 2013
TrabectedinAllavena, Paola; Germano, Giovanni; Belgiovine, Cristina; D’Incalci, Maurizio; Mantovani, Alberto · OncoImmunology · 2013
Trial WatchVacchelli, Erika; Aranda, Fernando; Eggermont, Alexander; Galon, Jérôme; Sautès-Fridman, Catherine; Cremer, Isabelle; Zitvogel, Laurence; Kroemer, Guido; Galluzzi, Lorenzo · OncoImmunology · 2014
Trial watchVacchelli, Erika; Martins, Isabelle; Eggermont, Alexander; Fridman, Wolf Hervé; Galon, Jerome; Sautès-Fridman, Catherine; Tartour, Eric; Zitvogel, Laurence; Kroemer, Guido; Galluzzi, Lorenzo · OncoImmunology · 2012
Immune checkpointsChawla, Akhil; Philips, Anne V; Alatrash, Gheath; Mittendorf, Elizabeth · OncoImmunology · 2014